We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+23.01%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$900M
Cap. Flow
+$775M
Cap. Flow %
39.93%
Top 10 Hldgs %
51.62%
Holding
194
New
73
Increased
41
Reduced
31
Closed
42

Top Buys

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$24.5M
2
PPD
PPD, Inc. Common Stock
PPD
+$19M
3
OM icon
Outset Medical
OM
+$18.6M
4
AFIB
Acutus Medical Inc
AFIB
+$16.2M
5
VCEL icon
Vericel Corp
VCEL
+$14.9M

Top Sells

Rank Stock Value
1
LHCG
LHC Group LLC
LHCG
+$8.66M
2
INSP icon
Inspire Medical Systems
INSP
+$8.51M
3
LIVN icon
LivaNova
LIVN
+$7.29M
4
OSUR icon
OraSure Technologies
OSUR
+$6.64M
5
BSX icon
Boston Scientific
BSX
+$6.44M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Industrials 0.76%
3 Consumer Staples 0.45%
4 Energy 0.25%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IHI icon
26
PUT
iShares US Medical Devices ETF
IHI
$3.48B
$15M 0.77%
300,000
-828,000
-73% -$40.1M
RCM
27
DELISTED
R1 RCM Inc. Common Stock
RCM
$14.7M 0.76%
856,840
-9,004
-1% -$131K
XENT
28
DELISTED
Intersect ENT, Inc
XENT
$14M 0.72%
860,816
-163,558
-16% -$2.96M
PROF
29
Profound Medical
PROF
$250M
$13.8M 0.71%
780,567
+207,011
+36% +$3.29M
NTRA icon
30
Natera
NTRA
$45.2B
$13.7M 0.71%
+190,000
New +$10.8M
MASI
31
PUT
DELISTED
Masimo
MASI
$13M 0.67%
55,000
+40,000
+267% +$8.97M
IVC
32
DELISTED
Invacare Corporation
IVC
$12.6M 0.65%
1,669,025
+73,416
+5% +$509K
PSNL icon
33
Personalis
PSNL
$1.51B
$11.5M 0.59%
531,271
+444,060
+509% +$8.82M
ALXN
34
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$11.4M 0.59%
100,000
-104,000
-51% -$11.2M
ZBH icon
35
Zimmer Biomet
ZBH
$18.4B
$11.1M 0.57%
84,308
+7,416
+10% +$969K
SIBN icon
36
SI-BONE Inc
SIBN
$845M
$10.9M 0.56%
458,509
-15,194
-3% -$302K
ADPT icon
37
Adaptive Biotechnologies
ADPT
$3.96B
$10.9M 0.56%
223,400
+156,700
+235% +$6.59M
ISRG icon
38
PUT
Intuitive Surgical
ISRG
$142B
$10.6M 0.55%
+45,000
New +$10.1M
DXCM icon
39
DexCom
DXCM
$34.2B
$10.6M 0.55%
102,732
+4,800
+5% +$501K
SYK icon
40
PUT
Stryker
SYK
$133B
$10.4M 0.54%
50,000
-103,000
-67% -$20M
AMGN icon
41
CALL
Amgen
AMGN
$225B
$10.2M 0.52%
+40,000
New +$9.91M
PACB icon
42
Pacific Biosciences
PACB
$339M
$9.87M 0.51%
+1,000,000
New +$5.76M
TXG icon
43
10x Genomics
TXG
$7.39B
$9.32M 0.48%
74,720
+30,800
+70% +$3.23M
IMMU
44
DELISTED
Immunomedics Inc
IMMU
$8.5M 0.44%
100,000
-45,445
-31% -$2.3M
FOLD
45
CALL
DELISTED
Amicus Therapeutics
FOLD
$8.47M 0.44%
+600,000
New +$8.74M
INSP icon
46
CALL
Inspire Medical Systems
INSP
$1.67B
$8.39M 0.43%
+65,000
New +$7.16M
IMDX
47
Insight Molecular Diagnostics
IMDX
$141M
$8.37M 0.43%
301,127
+1,941
+0.6% +$55.7K
GH icon
48
Guardant Health
GH
$22B
$8.28M 0.43%
74,092
+11,192
+18% +$1.02M
KIDS icon
49
OrthoPediatrics
KIDS
$648M
$8.19M 0.42%
178,418
+6,305
+4% +$293K
DGX icon
50
PUT
Quest Diagnostics
DGX
$26.2B
$8.01M 0.41%
+70,000
New +$8.27M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Pura Vida Investments held 194 positions worth $1.94B, up 87% from $1.04B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments deployed $775M of net new capital in Q3 2020, opening 73 new positions and adding to 41 existing holdings. Its largest new stake was Cooper Companies: 320,000 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was LHC Group LLC, an estimated $8.66M trimmed.

  • Pura Vida Investments's largest Q3 2020 buy was Cooper Companies: 320,000 shares worth $27M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q3 2020, an estimated $11.6M increase.
  • Pura Vida Investments's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $8.66M.
  • Pura Vida Investments fully exited LivaNova in Q3 2020, selling an estimated $7.29M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $1.94B portfolio in Q3 2020.
  • Pura Vida Investments opened 73 new positions and closed 42 in Q3 2020.
  • Pura Vida Investments's portfolio value rose 87% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.